Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2006-12-5
pubmed:abstractText
Huntington's disease has an increase in the activated calpain, which is enhanced by the NMDA receptor activation. We investigated the neuroprotective effect of memantine in 3-nitropropionic acid (3NP)-induced striatal degeneration model. Either memantine (20 mg/kg/day) or PBS was intraperitoneally administered for five days with 3NP continuous infusion. In the memantine-treated group, the striatal lesion volume, the number of TUNEL+ cells, and Fluoro-Jade C+ degenerating neurons were all decreased. Memantine increased Bcl-xl and decreased Bax level. Memantine also exerted an inhibitory effect on the micro-calpain level and decreased the huntingtin proteolytic fragments. Those rats treated with memantine showed less degree of weight loss at 5 days. Subsequently, memantine was found to have neuroprotective effects and save striatal cells with decreasing calpain levels in the 3NP model of Huntington's disease.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/3-nitropropionic acid, http://linkedlifedata.com/resource/pubmed/chemical/Apoptosis Regulatory Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Calpain, http://linkedlifedata.com/resource/pubmed/chemical/Excitatory Amino Acid Antagonists, http://linkedlifedata.com/resource/pubmed/chemical/Huntington protein, mouse, http://linkedlifedata.com/resource/pubmed/chemical/Memantine, http://linkedlifedata.com/resource/pubmed/chemical/Nerve Tissue Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Neuroprotective Agents, http://linkedlifedata.com/resource/pubmed/chemical/Neurotoxins, http://linkedlifedata.com/resource/pubmed/chemical/Nitro Compounds, http://linkedlifedata.com/resource/pubmed/chemical/Nuclear Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Peptide Fragments, http://linkedlifedata.com/resource/pubmed/chemical/Propionic Acids
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
0006-8993
pubmed:author
pubmed:issnType
Print
pubmed:day
6
pubmed:volume
1118
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
199-207
pubmed:meshHeading
pubmed-meshheading:16959224-Animals, pubmed-meshheading:16959224-Apoptosis Regulatory Proteins, pubmed-meshheading:16959224-Calpain, pubmed-meshheading:16959224-Cell Death, pubmed-meshheading:16959224-Corpus Striatum, pubmed-meshheading:16959224-Disease Models, Animal, pubmed-meshheading:16959224-Down-Regulation, pubmed-meshheading:16959224-Excitatory Amino Acid Antagonists, pubmed-meshheading:16959224-Huntington Disease, pubmed-meshheading:16959224-Male, pubmed-meshheading:16959224-Memantine, pubmed-meshheading:16959224-Nerve Degeneration, pubmed-meshheading:16959224-Nerve Tissue Proteins, pubmed-meshheading:16959224-Neurons, pubmed-meshheading:16959224-Neuroprotective Agents, pubmed-meshheading:16959224-Neurotoxins, pubmed-meshheading:16959224-Nitro Compounds, pubmed-meshheading:16959224-Nuclear Proteins, pubmed-meshheading:16959224-Peptide Fragments, pubmed-meshheading:16959224-Propionic Acids, pubmed-meshheading:16959224-Rats, pubmed-meshheading:16959224-Rats, Sprague-Dawley
pubmed:year
2006
pubmed:articleTitle
Memantine reduces striatal cell death with decreasing calpain level in 3-nitropropionic model of Huntington's disease.
pubmed:affiliation
Department of Neurology, Clinical Research Institute, Seoul National University Hospital, Chongro-Gu, Seoul, South Korea.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't